Target intelligence / Profile preview

Sebocyte lipogenesis

Molecular classification
Other
01

Overview

Sebocyte lipogenesis refers to the complex biological process by which specialized epithelial cells in the sebaceous glands, known as sebocytes, synthesize and secrete sebum. Sebum is a unique mixture of lipids, including triglycerides, wax esters, and squalene, that is essential for maintaining the skin's moisture barrier and providing antimicrobial protection (Zouboulis et al., 2004, Journal of Investigative Dermatology). However, the dysregulation of this process—specifically the overproduction of sebum—is a primary driver in the pathogenesis of Acne vulgaris and seborrheic dermatitis (Makrantonaki et al., 2011, Dermato-endocrinology). Lipogenesis is tightly regulated by hormonal signals, particularly androgens acting through the androgen receptor, and metabolic enzymes such as acetyl-CoA carboxylase (ACC) and stearoyl-CoA desaturase (SCD) (Thiboutot, 2004, Journal of Investigative Dermatology). Therapeutic strategies targeting this pathway include systemic retinoids like isotretinoin, which reduce sebaceous gland size and activity by inducing sebocyte apoptosis, and topical agents like clascoterone that block androgenic stimulation (Hebert et al., 2020, JAMA Dermatology). While highly effective for dermatological conditions, the suppression of sebaceous activity often results in clinical challenges such as significant skin dryness and irritation due to the loss of protective surface lipids.

Other names
Sebaceous gland activitySebogenesisSebum productionSebocyte lipid synthesis
02

Mechanism of action

Inhibition of rate-limiting lipid biosynthesis enzymes (e.g., Acetyl-CoA carboxylase, Stearoyl-CoA desaturase 1), antagonism of the androgen receptor to reduce hormonal stimulation, or induction of sebocyte apoptosis and differentiation via retinoid signaling.

03

Biological functions

Lipid metabolismSkin barrier maintenanceInnate immunityThermoregulation
04

Disease associations

Acne vulgarisSeborrheic dermatitisSteatocystoma multiplexSebaceous hyperplasia
05

Safety considerations

Xerosis (severe skin dryness)CheilitisSkin irritationImpaired epidermal barrier functionTeratogenicity (for systemic retinoids)
06

Interacting drugs

Isotretinoin

5 more in the full profile.

07

Biomarkers

Sebum excretion rate (SER)Squalene levelsSebocyte volumeSkin surface lipidomic profile

Beyond the preview

Go deeper on Sebocyte lipogenesis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sebocyte lipogenesis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call